Oleuropein / HDAC2 Cancer Research Results

OLE, Oleuropein: Click to Expand ⟱

Features:

Oleocanthal is essentially found ONLY in: Fresh, unrefined extra-virgin olive oil (EVOO)
It is part of the pungent, throat-stinging phenolic fraction that disappears in refined oils.

Oleuropein (OLEU) — a secoiridoid polyphenol from olive leaf and olive fruit/extra-virgin olive oil; major in-vivo related phenolic is hydroxytyrosol (via hydrolysis/metabolism). Sources: olive leaf extract (standardized to oleuropein), EVOO phenolics.

Primary mechanisms (conceptual rank):
1) Redox modulation (ROS ↓ in normal tissue; stress/hormesis; NRF2 ↑ context-dependent)
2) Anti-inflammatory transcription suppression (NF-κB ↓)
3) Anti-proliferative signaling in cancer models (PI3K/AKT/mTOR ↓; MAPK modulation; apoptosis ↑; model-dependent)
4) Anti-angiogenic / hypoxia coupling (HIF-1α/VEGF ↓; model-dependent)

Bioavailability / PK relevance: Human data show absorption/metabolism after oral olive leaf extract; circulating forms are largely metabolites (and hydroxytyrosol-related), with limited free parent compound exposure. :contentReference[oaicite:0]{index=0}

In-vitro vs oral exposure: Many direct “anticancer” cytotoxic effects occur at micromolar concentrations that may exceed typical systemic exposure from supplements/foods (high concentration only for direct tumor cytotoxicity in many models). :contentReference[oaicite:1]{index=1}

Clinical evidence status: Nutraceutical/food bioactive with human data mainly for cardiometabolic/inflammation endpoints; oncology evidence largely preclinical/adjunct-hypothesis (no oncology approval).

Also available as a supplement usually labeled as Olive Leaf Extract. (20-50% concentrations)
- commonly used in CSC (Cancer Stem Cell) research.
Main CSC mechanisms:
-Inhibits Wnt/β-catenin — a core CSC survival pathway
-↓ALDH (Reduces ALDH-high CSC subpopulations)
-downregulates stemness geens: SOX2/OCT4/Nanog → reduced sphere formation/self-renewal.

Oleuropein — Cancer vs Normal Cell Pathway Map

Rank	Pathway / Axis	Cancer Cells	Normal Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS	↑ or ↓ (dose-/model-dependent)	↓ (primary)	P/R	Redox reprogramming	Normal tissue: antioxidant/lipid-peroxidation reduction common. Cancer: higher exposures can induce stress/apoptosis; direction varies by model and co-stressors.
2	NF-κB / cytokine programs	↓	↓	R/G	Anti-inflammatory / anti-survival transcription	Commonly reported mechanism for oleuropein/olive phenolics. :contentReference[oaicite:3]{index=3}
3	NRF2 (protective vs resistance role)	↔ / ↑ (context-dependent)	↑	R/G	Antioxidant gene induction	NRF2 modulation is frequently discussed for olive polyphenols; in cancer contexts can be double-edged (cytoprotection/resistance). :contentReference[oaicite:4]{index=4}
4	PI3K/AKT/mTOR	↓ (model-dependent; high concentration only)	↔	R/G	Reduced anabolic survival signaling	Reported across cancer models and olive phenolic literature; translation depends on exposure. :contentReference[oaicite:5]{index=5}
5	Intrinsic apoptosis (Bax↑/Bcl-2↓; caspases)	↑ (model-dependent; high concentration only)	↔	R/G	Mitochondrial apoptosis	Common downstream endpoint in preclinical cancer work; often coupled to redox and PI3K/AKT shifts. :contentReference[oaicite:6]{index=6}
6	HIF-1α / VEGF (angiogenesis)	↓ (model-dependent)	↔	G	Reduced hypoxia-adaptation / vascular support	Typically secondary; varies strongly by model and readout.
7	Cell cycle checkpoints	↓ proliferation (model-dependent)	↔	G	Cytostatic growth restraint	Often reported as G0/G1 or G2/M arrest in vitro; exposure gap is common. :contentReference[oaicite:7]{index=7}
8	Ferroptosis	↔ (limited / context-dependent)	↔	R/G	Not canonical	Olive phenolics can influence lipid peroxidation, but a consistent oleuropein-driven ferroptosis program is not a core claim in the main reviews.
9	Ca²⁺ signaling	↔	↔	P/R	No primary role	Include only if a specific ER/mitochondrial stress model measures Ca²⁺ endpoints.
10	Clinical Translation Constraint	↓ (constraint)	↓ (constraint)	—	Metabolite-dominant exposure	Human absorption/metabolism exists, but many tumor-directed effects rely on higher in-vitro exposures; extract standardization and formulation matter. :contentReference[oaicite:8]{index=8}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

Oleuropein — AD relevance: Oleuropein/olive leaf phenolics show neuroprotection in models via oxidative- and heat-shock/proteostasis stress responses, with reported reduction of Aβ and tau proteotoxicity in preclinical systems; human AD disease-modifying evidence is not established.

Primary mechanisms (conceptual rank):
1) ↓ Oxidative stress (ROS ↓; lipid peroxidation ↓; NRF2-linked defense ↑)
2) ↓ Neuroinflammation (NF-κB tone ↓)
3) Proteostasis support (heat-shock/stress-response pathways; context-dependent)
4) Aβ/tau proteotoxicity ↓ (preclinical)

Bioavailability / PK relevance: Human absorption/metabolism supports systemic exposure mainly as metabolites; brain relevance likely chronic/adaptive. :contentReference[oaicite:9]{index=9}

Clinical evidence status: Predominantly preclinical for AD mechanisms; limited AD-specific clinical endpoint evidence.

Oleuropein — AD / Neurodegeneration Pathway Map

Rank	Pathway / Axis	Cells	TSF	Primary Effect	Notes / Interpretation
1	ROS / lipid peroxidation	↓	P/R	Reduced oxidative burden	Central neuroprotection rationale for olive polyphenols (includes oleuropein/hydroxytyrosol pathways). :contentReference[oaicite:11]{index=11}
2	NRF2 axis	↑ (context-dependent)	R/G	Stress-defense upshift	NRF2 modulation is repeatedly discussed for olive polyphenols in cognition-related health framing. :contentReference[oaicite:12]{index=12}
3	Neuroinflammation (NF-κB / cytokines)	↓	R/G	Lower inflammatory stress	Often paired with antioxidant effects; model-dependent magnitude.
4	Proteostasis / heat-shock stress responses	↑ (supportive)	R/G	Improved handling of misfolded proteins	Oleuropein-rich olive leaf extract reduced Aβ and tau proteotoxicity via oxidative/heat-shock stress regulation in a C. elegans model. :contentReference[oaicite:13]{index=13}
5	Aβ / tau proteotoxicity	↓ (preclinical)	G	Reduced pathology-linked toxicity	Evidence is stronger in models than in biomarker-confirmed human AD studies. :contentReference[oaicite:14]{index=14}
6	Ca²⁺ homeostasis / excitotoxic vulnerability	↔ / stabilized (indirect)	P/R	Supportive (secondary)	Typically secondary to mitochondrial/redox support unless a study explicitly measures Ca²⁺ endpoints.
7	Clinical Translation Constraint	↓ (constraint)	—	Preclinical-dominant AD evidence	Most AD-relevant mechanisms are model-based; human AD efficacy endpoints remain limited. :contentReference[oaicite:15]{index=15}

TSF legend: P: 0–30 min; R: 30 min–3 hr; G: >3 hr

HDAC2, Histone Deacetylase 2: Click to Expand ⟱

Source:

Type:

HDAC2 is a member of the class I histone deacetylase family that removes acetyl groups from lysine residues on histone proteins.

• This deacetylation usually promotes chromatin compaction, leading to transcriptional repression of genes involved in cell differentiation, apoptosis, and cell cycle regulation.
• HDAC2, along with its relatives HDAC1 and others, is often found as part of multiprotein corepressor complexes that regulate gene expression in both normal and cancer cells.

2. Role of HDAC2 in Cancer
• Overexpression and Dysregulation:
– In several types of cancer, HDAC2 is overexpressed or dysregulated, contributing to an altered transcriptional profile.
– Elevated HDAC2 levels can lead to the suppression of tumor suppressor genes and genes involved in cell-cycle checkpoints or apoptosis, facilitating tumor progression.

• Impact on the Tumor Microenvironment:
– HDAC2 activity influences not only tumor cells but also the surrounding stromal and immune cells, affecting inflammatory responses and immune evasion strategies.

Scientific Papers found: Click to Expand⟱

4643-

OLE,

HT,

Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine

Review,

Var,

TumCCA↑, Apoptosis↑, ER Stress↑, UPR↑, CHOP↑, ROS↑, Bcl-2↓, NOX4↑, Hif1a↓, MMP2↓, MMP↓, VEGF↓, Akt↓, NF-kB↓, p65↓, SIRT3↓, mTOR↓, Catalase↓, SOD2↓, FASN↓, STAT3↓, HDAC2↓, HDAC3↓, BAD↑, BAX↑, Bak↑, Casp3↑, Casp9↑, PARP↑, P53↑, P21↑, p27↑, Half-Life↝, BioAv↓, BioAv↓, selectivity↑, RadioS↑, *ROS↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *NRF2↑, *chemoP↑, *Inflam↓, PPARγ↑,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Catalase↑, 1, GSH↑, 1, MDA↓, 1, NRF2↑, 1, ROS↓, 1, SOD↑, 1,

Immune & Inflammatory Signaling ⓘ

Inflam↓, 1,

Functional Outcomes ⓘ

chemoP↑, 1,
Total Targets: 8

Scientific Paper Hit Count for: HDAC2, Histone Deacetylase 2

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells

Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:375  Target#:984  State#:%  Dir#:1
  wNotes=0  sortOrder:rid,rpid

Oleuropein / HDAC2 Cancer Research Results

Oleuropein — Cancer vs Normal Cell Pathway Map

Oleuropein — AD / Neurodegeneration Pathway Map

Pathway results for Effect on Cancer / Diseased Cells:

Redox & Oxidative Stress ⓘ

Mitochondria & Bioenergetics ⓘ

Core Metabolism/Glycolysis ⓘ

Cell Death ⓘ

Protein Folding & ER Stress ⓘ

DNA Damage & Repair ⓘ

Cell Cycle & Senescence ⓘ

Proliferation, Differentiation & Cell State ⓘ

Migration ⓘ

Angiogenesis & Vasculature ⓘ

Immune & Inflammatory Signaling ⓘ

Drug Metabolism & Resistance ⓘ

Pathway results for Effect on Normal Cells:

Redox & Oxidative Stress ⓘ

Immune & Inflammatory Signaling ⓘ

Functional Outcomes ⓘ

Home Page